Search Research Articles
Browse Research Categories

IGF-1 LR3 Peptide Research

IGF-1 LR3 (Long R3 IGF-1) is a recombinant analog of Insulin-like Growth Factor-1 modified with an arginine substitution and a 13-amino-acid N-terminal extension that significantly reduces IGFBP binding affinity, extending its half-life to approximately 20–30 hours compared to IGF-1’s 12–15 minutes. This prolonged activity allows systemic distribution and sustained anabolic signaling across multiple tissue types. Research has explored its applications in muscle protein synthesis, cellular proliferation, metabolic regulation, tissue repair, and growth factor biology. This section covers scientific studies on IGF-1 LR3 and its long-acting growth factor and body composition peptide research applications.

Other Popular Research Categories

Newest IGF-1 LR3 Research

IGF-1 LR3 Peptide Research – Complete Guide

IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1, engineered with structural modifications that extend its half-life to 20-30 hours and reduce binding to carrier proteins that normally limit its activity. This IGF-1 LR3 peptide research guide covers its molecular mechanisms, preclinical findings across muscle, bone, metabolic, and neurological models, pharmacokinetic properties, and the significant safety and regulatory considerations...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0